These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 28459790

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Idarucizumab for Dabigatran Reversal Guideline.
    Reardon DP, Owusu K.
    Crit Pathw Cardiol; 2016 Jun; 15(2):33-5. PubMed ID: 27183250
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Effect of Age and Renal Function on Idarucizumab Pharmacokinetics and Idarucizumab-Mediated Reversal of Dabigatran Anticoagulant Activity in a Randomized, Double-Blind, Crossover Phase Ib Study.
    Glund S, Stangier J, van Ryn J, Schmohl M, Moschetti V, Haazen W, De Smet M, Gansser D, Norris S, Lang B, Reilly P, Kreuzer J.
    Clin Pharmacokinet; 2017 Jan; 56(1):41-54. PubMed ID: 27317414
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Dose requirements for idarucizumab reversal of dabigatran in a lethal porcine trauma model with continuous bleeding.
    Honickel M, Spronk HM, Rossaint R, Stoppe C, van Ryn J, Ten Cate H, Grottke O.
    Thromb Haemost; 2017 Jun 28; 117(7):1370-1378. PubMed ID: 28424818
    [Abstract] [Full Text] [Related]

  • 27. Assessment of patients post reversal with idarucizumab.
    Raco V, Ahuja T, Green D.
    J Thromb Thrombolysis; 2018 Nov 28; 46(4):466-472. PubMed ID: 30120649
    [Abstract] [Full Text] [Related]

  • 28. [The first use of iv. idarucizumab for dabigatran reversal in Hungary].
    Driesz L, Barabás É, Bodócs I, Szántó Z, Herr G, Bencsik G, Pál L, Borbola J.
    Orv Hetil; 2017 Mar 28; 158(10):387-392. PubMed ID: 28270004
    [Abstract] [Full Text] [Related]

  • 29. Real-life experience with the specific reversal agent idarucizumab for the management of emergency situations in dabigatran-treated patients: a series of 11 cases.
    Vosko MR, Bocksrucker C, Drwiła R, Dulíček P, Hauer T, Mutzenbach J, Schlimp CJ, Špinler D, Wolf T, Zugwitz D.
    J Thromb Thrombolysis; 2017 Apr 28; 43(3):306-317. PubMed ID: 28210988
    [Abstract] [Full Text] [Related]

  • 30. Early-access programme in emergency care: idarucizumab use for rapid dabigatran reversal in critical care patients.
    Elalamy I, Crisan O, Gruenenfelder F, Benarousse G, Tazarourte K.
    Eur J Emerg Med; 2019 Jun 28; 26(3):230-231. PubMed ID: 31033622
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Refractory Dabigatran-Induced Hemorrhage Despite Multiple Idarucizumab Administration and Renal Replacement Therapy.
    Flynn F, Richard G, Dobrescu MA, Bouchard J, Williamson D, Brindamour D, Charbonney E, Dupuis S.
    J Pharm Pract; 2022 Apr 28; 35(2):302-307. PubMed ID: 32985337
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Idarucizumab for dabigatran overdose.
    Peetermans M, Pollack C, Reilly P, Liesenborghs L, Jacquemin M, Levy JH, Weitz JI, Verhamme P.
    Clin Toxicol (Phila); 2016 Sep 28; 54(8):644-6. PubMed ID: 27224445
    [Abstract] [Full Text] [Related]

  • 38. Idarucizumab for dabigatran overdose in a child.
    Shapiro S, Bhatnagar N, Khan A, Beavis J, Keeling D.
    Br J Haematol; 2018 Feb 28; 180(3):457-459. PubMed ID: 27734469
    [No Abstract] [Full Text] [Related]

  • 39. Idarucizumab-facilitated intravenous thrombolysis in acute stroke with dabigatran: Two cases with hemorrhagic transformation.
    Tsai YT, Hsiao YJ, Tsai LK, Yen PS, Lin FY, Lu CH, Fang CW.
    J Neurol Sci; 2018 May 15; 388():155-157. PubMed ID: 29627012
    [No Abstract] [Full Text] [Related]

  • 40. Thrombolytic Therapy in Severe Cardioembolic Stroke After Reversal of Dabigatran with Idarucizumab: Case Report and Literature Review.
    Ohya Y, Makihara N, Wakisaka K, Morita T, Ago T, Kitazono T, Takaba H.
    J Stroke Cerebrovasc Dis; 2018 Jul 15; 27(7):e128-e131. PubMed ID: 29555397
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.